Expert Video - What questions should I ask my doctor about mutation-driven MDS treatments?
MDS expert Valeria Santini, MD, of the University of Florence, advises patients to ask their doctor which genetic tests are available for suspected myelodysplastic syndromes (MDS). Karyotype testing for chromosomal abnormalities in MDS is essential, as is genetic testing that can find a wide array of mutations, including less common ones. Patients should ask about testing to look for new mutations during and after treatment so treatment can be adjusted if necessary.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.